{"id":"W2965372017","doi":"10.1200/jco.2013.31.15_suppl.6041","title":"Evaluation of potential predictive markers of efficacy of dacomitinib in patients (pts) with recurrent/metastatic SCCHN from a phase II trial.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Pfizer (Canada); University Health Network; Ottawa Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; Juravinski Cancer Centre; Hôpital Notre-Dame; BC Cancer Agency; Princess Margaret Cancer Centre; University of Toronto; Centre Hospitalier de l’Université de Montréal; London Health Sciences Centre","funders":"","keywords":"Medicine; PTEN; Oncology; Internal medicine; Clinical endpoint; Immunohistochemistry; Clinical trial; PI3K/AKT/mTOR pathway; Apoptosis; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00441764,0.000598887,0.001582109,0.0003602849,0.000233235,0.0008810603,0.0003267366,0.0005809598,0.001989913],"category_scores_gemma":[0.003170253,0.0002815094,0.001151815,0.0005301329,0.0003064814,0.0006088913,0.0003560214,0.001014792,0.000402037],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005427602,"about_ca_system_score_gemma":0.0005040387,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002548375,"about_ca_topic_score_gemma":0.0004749643,"domain_scores_codex":[0.9990926,0.0004472577,0.00007780339,0.0001843928,0.0001352948,0.00006275589],"domain_scores_gemma":[0.9979068,0.0008343318,0.0006019444,0.0001524682,0.0001318273,0.0003727296],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.4064474,0.003333034,0.4307463,0.001065298,0.004370441,0.0004499967,0.0003060633,0.004598136,0.0193616,0.0001760906,0.001839978,0.1273056],"study_design_scores_gemma":[0.06166207,0.1896333,0.7186454,0.0001442236,0.005616058,0.002216919,0.0001201172,0.009223849,0.006248342,0.0005380562,0.005894259,0.00005745418],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994176,0.003333041,0.0004237355,0.0001088568,0.00002165173,0.000317457,0.0007894392,0.00002325669,0.0008065144],"genre_scores_gemma":[0.996123,0.0006169088,0.000448638,0.0001204277,0.00003820439,0.0002397687,0.002050731,0.000006415467,0.0003558422],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00441764,"threshold_uncertainty_score":0.02336299,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09366372852937581,"score_gpt":0.5018475318425942,"score_spread":0.4081838033132184,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}